{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:17:59Z","timestamp":1790036279114,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","award":["Research Fellowship for Young Investigators 2019"],"award-info":[{"award-number":["Research Fellowship for Young Investigators 2019"]}],"id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grant-in-Aid for Scientific Research(Japan Society for the Promotion of Scienc","award":["19K17626"],"award-info":[{"award-number":["19K17626"]}]},{"name":"Japanese Ministry of Health, Labour and Welfare research grants","award":["No.16ek0109127h0002"],"award-info":[{"award-number":["No.16ek0109127h0002"]}]},{"name":"Japanese Ministry of Health, Labour and Welfare research grants","award":["No.16ek0109127h0002"],"award-info":[{"award-number":["No.16ek0109127h0002"]}]},{"name":"Japanese Ministry of Health, Labour and Welfare research grants","award":["No.16ek0109127h0002"],"award-info":[{"award-number":["No.16ek0109127h0002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prognostic value of mixed venous oxygen tension (PvO<jats:sub>2<\/jats:sub>) at pulmonary hypertension diagnosis treated with selective pulmonary vasodilators remains unclear. This study sought to investigate the association of PvO<jats:sub>2<\/jats:sub> with long-term prognosis in pulmonary arterial hypertension (PAH) and medically treated chronic thromboembolic pulmonary hypertension (CTEPH) and to identify the distinct mechanisms influencing tissue hypoxia in patients with CTEPH or PAH.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We retrospectively analyzed data from 138 (age: 50.2\u2009\u00b1\u200916.6\u00a0years, 81.9% women) and 268 (age: 57.4\u2009\u00b1\u200913.1\u00a0years, 72.8% women) patients with PAH and CTEPH, respectively, diagnosed at our institution from 1983 to 2018. We analyzed the survival rates of patients with\/without tissue hypoxia (PvO<jats:sub>2<\/jats:sub>\u2009&lt;\u200935\u00a0mmHg) and identified their prognostic factors based on the pulmonary hypertension risk stratification guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Survival was significantly poorer in patients with tissue hypoxia than in those without it for PAH (<jats:italic>P<\/jats:italic>\u2009=\u20090.001) and CTEPH (<jats:italic>P<\/jats:italic>\u2009=\u20090.017) treated with selective pulmonary vasodilators. In patients with PAH, PvO<jats:sub>2<\/jats:sub> more strongly correlated with prognosis than other hemodynamic prognostic factors regardless of selective pulmonary vasodilators usage. PvO<jats:sub>2<\/jats:sub> was the only significant prognostic factor in patients with CTEPH treated with pulmonary hypertension medication. Patients with CTEPH experiencing tissue hypoxia exhibited significantly poorer survival than those in the intervention group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). PvO<jats:sub>2<\/jats:sub> more strongly correlated with the cardiac index (CI) than the alveolar-arterial oxygen gradient (A-aDO<jats:sub>2<\/jats:sub>) in PAH; whereas in CTEPH, PvO<jats:sub>2<\/jats:sub> was more strongly correlated with A-aDO<jats:sub>2<\/jats:sub> than with CI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PvO<jats:sub>2<\/jats:sub> may represent a crucial prognostic factor for pulmonary hypertension. The prognostic impact of tissue hypoxia affects different aspects of PAH and CTEPH, thereby reflecting their distinct pathogenesis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12890-022-02073-0","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:03:42Z","timestamp":1658329422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jun","family":"Nagata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Sakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"2073_CR1","first-page":"CD012621","volume":"1","author":"H Barnes","year":"2019","unstructured":"Barnes H, Brown Z, Burns A, Williams T. Phosphodiesterase 5 inhibitors for pulmonary hypertension. Cochrane Database Syst Rev. 2019;1:CD012621.","journal-title":"Cochrane Database Syst Rev"},{"key":"2073_CR2","doi-asserted-by":"publisher","first-page":"1801904","DOI":"10.1183\/13993003.01904-2018","volume":"53","author":"A Frost","year":"2019","unstructured":"Frost A, Badesch D, Gibbs JSR, Gopalan D, Khanna D, Manes A, et al. Diagnosis of pulmonary hypertension. Eur Respir J. 2019;53:1801904.","journal-title":"Eur Respir J"},{"key":"2073_CR3","doi-asserted-by":"publisher","first-page":"S1767","DOI":"10.21037\/jtd.2019.09.14","volume":"11","author":"V Parikh","year":"2019","unstructured":"Parikh V, Bhardwaj A, Nair A. Pharmacotherapy for pulmonary arterial hypertension. J Thorac Dis. 2019;11:S1767\u201381.","journal-title":"J Thorac Dis"},{"key":"2073_CR4","doi-asserted-by":"publisher","first-page":"1801889","DOI":"10.1183\/13993003.01889-2018","volume":"53","author":"N Gali\u00e8","year":"2019","unstructured":"Gali\u00e8 N, Channick RN, Frantz RP, Gr\u00fcnig E, Jing ZC, Moiseeva O, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53:1801889.","journal-title":"Eur Respir J"},{"key":"2073_CR5","doi-asserted-by":"publisher","first-page":"1801915","DOI":"10.1183\/13993003.01915-2018","volume":"53","author":"NH Kim","year":"2019","unstructured":"Kim NH, Delcroix M, Jais X, Madani MM, Matsubara H, Mayer E, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2019;53:1801915.","journal-title":"Eur Respir J"},{"key":"2073_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Gali\u00e8","year":"2016","unstructured":"Gali\u00e8 N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67\u2013119.","journal-title":"Eur Heart J"},{"key":"2073_CR7","doi-asserted-by":"publisher","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","volume":"50","author":"A Boucly","year":"2017","unstructured":"Boucly A, Weatherald J, Savale L, Ja\u00efs X, Cottin V, Prevot G, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50:1700889.","journal-title":"Eur Respir J"},{"key":"2073_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/14017431.2020.1783456","volume":"55","author":"A Sandqvist","year":"2021","unstructured":"Sandqvist A, Kylhammar D, Bartfay SE, Hesselstrand R, Hjalmarsson C, Kavianipour M, et al. Risk stratification in chronic thromboembolic pulmonary hypertension predicts survival. Scand Cardiovasc J. 2021;55:43\u20139.","journal-title":"Scand Cardiovasc J"},{"key":"2073_CR9","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1183\/09031936.00079512","volume":"41","author":"J Hurdman","year":"2013","unstructured":"Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, et al. Pulmonary hypertension in COPD: results from the Aspire registry. Eur Respir J. 2013;41:1292\u2013301.","journal-title":"Eur Respir J"},{"key":"2073_CR10","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJM198305053081801","volume":"308","author":"Y Kawakami","year":"1983","unstructured":"Kawakami Y, Kishi F, Yamamoto H, Miyamoto K. Relation of oxygen delivery, mixed venous oxygenation, and pulmonary hemodynamics to prognosis in chronic obstructive pulmonary disease. N Engl J Med. 1983;308:1045\u20139.","journal-title":"N Engl J Med"},{"key":"2073_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1378\/chest.66.2.122","volume":"66","author":"JC Mithoefer","year":"1974","unstructured":"Mithoefer JC, Holford FD, Keighley JF. The effect of oxygen administration on mixed venous oxygenation in chronic obstructive pulmonary disease. Chest. 1974;66:122\u201332.","journal-title":"Chest"},{"key":"2073_CR12","first-page":"259","volume":"117","author":"JC Mithoefer","year":"1978","unstructured":"Mithoefer JC, Ramirez C, Cook W. The effect of mixed venous oxygenation on arterial blood in chronic obstructive pulmonary disease: the basis for a classification. Am Rev Respir Dis. 1978;117:259\u201364.","journal-title":"Am Rev Respir Dis"},{"key":"2073_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1164\/rccm.201010-1584CI","volume":"184","author":"KR Walley","year":"2011","unstructured":"Walley KR. Use of central venous oxygen saturation to guide therapy. Am J Respir Crit Care Med. 2011;184:514\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"2073_CR14","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000194277","volume":"40","author":"L Radwan","year":"1980","unstructured":"Radwan L, Daum S. Evaluation of mixed venous oxygenation on the basis of arterial oxygen tension in chronic lung diseases. Respiration. 1980;40:194\u2013200.","journal-title":"Respiration"},{"key":"2073_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/resp.13574","volume":"25","author":"R Suda","year":"2020","unstructured":"Suda R, Tanabe N, Terada J, Naito A, Kasai H, Nishimura R, et al. Pulmonary hypertension with a low cardiac index requires a higher PaO2 level to avoid tissue hypoxia. Respirology. 2020;25:97\u2013103.","journal-title":"Respirology"},{"key":"2073_CR16","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.chest.2020.06.053","volume":"158","author":"G Khirfan","year":"2020","unstructured":"Khirfan G, Almoushref A, Naal T, Abuhalimeh B, Dweik RA, Heresi GA, et al. Mixed venous oxygen saturation is a better prognosticator than cardiac index in pulmonary arterial hypertension. Chest. 2020;158:2546\u201355.","journal-title":"Chest"},{"key":"2073_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1378\/chest.98.1.14","volume":"98","author":"KS Kapitan","year":"1990","unstructured":"Kapitan KS, Clausen JL, Moser KM. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy. Chest. 1990;98:14\u20139.","journal-title":"Chest"},{"key":"2073_CR18","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijcard.2012.10.026","volume":"168","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Huscher D, Ghofrani HA, Delcroix M, Distler O, Schweiger C, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry. Int J Cardiol. 2013;168:871\u201380.","journal-title":"Int J Cardiol"},{"key":"2073_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1253\/circj.CJ-17-0139","volume":"82","author":"Y Tamura","year":"2017","unstructured":"Tamura Y, Kumamaru H, Satoh T, Miyata H, Ogawa A, Tanabe N, et al. Effectiveness and outcome of pulmonary arterial hypertension-specific therapy in Japanese patients with pulmonary arterial hypertension. Circ J. 2017;82:275\u201382.","journal-title":"Circ J"},{"key":"2073_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1183\/09059180.00011112","volume":"18","author":"HA Ghofrani","year":"2009","unstructured":"Ghofrani HA, Grimminger F. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy. Eur Respir Rev. 2009;18:35\u201341.","journal-title":"Eur Respir Rev"},{"key":"2073_CR21","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1183\/09031936.00134506","volume":"29","author":"MM Hoeper","year":"2007","unstructured":"Hoeper MM, Pletz MW, Golpon H, Welte T. Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension. Eur Respir J. 2007;29:944\u201350.","journal-title":"Eur Respir J"},{"key":"2073_CR22","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1183\/09031936.97.10092066","volume":"10","author":"N Tanabe","year":"1997","unstructured":"Tanabe N, Okada O, Nakagawa Y, Masuda M, Kato K, Nakajima N, et al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J. 1997;10:2066\u201372.","journal-title":"Eur Respir J"},{"key":"2073_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00380-018-1284-4","volume":"34","author":"S Isobe","year":"2019","unstructured":"Isobe S, Itabashi Y, Kawakami T, Kataoka M, Kohsaka S, Tsugu T, et al. Increasing mixed venous oxygen saturation is a predictor of improved renal function after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Heart Vessels. 2019;34:688\u201397.","journal-title":"Heart Vessels"},{"key":"2073_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1183\/09031936.00058112","volume":"41","author":"DP Jenkins","year":"2013","unstructured":"Jenkins DP, Madani M, Mayer E, Kerr K, Kim N, Klepetko W, et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J. 2013;41:735\u201342.","journal-title":"Eur Respir J"},{"key":"2073_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jtcvs.2011.09.004","volume":"144","author":"K Ishida","year":"2012","unstructured":"Ishida K, Masuda M, Tanabe N, Matsumiya G, Tatsumi K, Nakajima N. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. J Thorac Cardiovasc Surg. 2012;144:321\u20136.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2073_CR26","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jtcvs.2010.11.024","volume":"141","author":"E Mayer","year":"2011","unstructured":"Mayer E, Jenkins D, Lindner J, D\u2019Armini A, Kloek J, Meyns B, et al. Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. J Thorac Cardiovasc Surg. 2011;141:702\u201310.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2073_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1113\/jphysiol.1919.sp001839","volume":"52","author":"A Krogh","year":"1919","unstructured":"Krogh A. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue. J Physiol. 1919;52:409\u201315.","journal-title":"J Physiol"},{"key":"2073_CR28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0034-5687(74)90025-5","volume":"20","author":"SM Tenney","year":"1974","unstructured":"Tenney SM. A theoretical analysis of the relationship between venous blood and mean tissue oxygen pressures. Respir Physiol. 1974;20:283\u201396.","journal-title":"Respir Physiol"},{"key":"2073_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/cc126","volume":"2","author":"FB Pl\u00f6tz","year":"1998","unstructured":"Pl\u00f6tz FB, van Lingen RA, Bos AP. Venous oxygen measurements in the inferior vena cava in neonates with respiratory failure. Crit Care. 1998;2:57\u201360.","journal-title":"Crit Care"},{"key":"2073_CR30","first-page":"437","volume":"42","author":"K Miyamoto","year":"1994","unstructured":"Miyamoto K, Kawakami Y. Pathophysiology of tissue hypoxia. Kokyu Junkan Respir Circ. 1994;42:437\u201344 (in Japanese).","journal-title":"Kokyu Junkan Respir Circ"},{"key":"2073_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1136\/hrt.80.2.151","volume":"80","author":"T Higenbottam","year":"1998","unstructured":"Higenbottam T, Butt AY, McMahon A, Westerbeck R, Sharples L. Long-term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension. Heart. 1998;80:151\u20135.","journal-title":"Heart"},{"key":"2073_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/hrt.70.4.366","volume":"70","author":"TW Higenbottam","year":"1993","unstructured":"Higenbottam TW, Spiegelhalter D, Scott JP, Fuster V, Dinh-Xuan AT, Caine N, et al. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J. 1993;70:366\u201370.","journal-title":"Br Heart J"},{"key":"2073_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","volume":"83","author":"K Fukuda","year":"2019","unstructured":"Fukuda K, Date H, Doi S, Fukumoto Y, Fukushima N, Hatano M, et al. Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017). Circ J. 2019;83:842\u2013945.","journal-title":"Circ J"},{"key":"2073_CR34","doi-asserted-by":"publisher","first-page":"2000673","DOI":"10.1183\/13993003.00673-2020","volume":"56","author":"O Sitbon","year":"2020","unstructured":"Sitbon O, Cottin V, Canuet M, Clerson P, Gressin V, Perchenet L, et al. Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension. Eur Respir J. 2020;56:2000673.","journal-title":"Eur Respir J"},{"key":"2073_CR35","doi-asserted-by":"publisher","first-page":"e0191869","DOI":"10.1371\/journal.pone.0191869","volume":"13","author":"G Khirfan","year":"2018","unstructured":"Khirfan G, Naal T, Abuhalimeh B, Newman J, Heresi GA, Dweik RA, et al. Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension. PLoS ONE. 2018;13:e0191869.","journal-title":"PLoS ONE"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-022-02073-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-022-02073-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T15:03:51Z","timestamp":1658329431000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-022-02073-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2073"],"URL":"https:\/\/doi.org\/10.1186\/s12890-022-02073-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the tenets of the amended Declaration of Helsinki. Patient identity was concealed in this study, and data were compiled according to the requirements of the Japanese Ministry of Health, Labour and Welfare, which is dedicated to privacy, information technology, and civil rights. The research protocol for this study was approved by the Research Ethics Committee of the Chiba University School of Medicine (Approval No.: 2584); we had already performed \"opt-out\" by notifying or disclosing information. Written informed consent was obtained from all patients who were enrolled since 2009, when this requirement became mandatory (Approval No.: 826). In the case of patients who died before 2008, written informed consent was obtained from their next of kin when we examined prognosis in the relevant study (Approval No.: 84). The study database was anonymized, and all experiments were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AS has received honoraria for lectures from Jansen Pharmaceutical K.K., Nippon Shinyaku Co, Ltd., and Mochida Seiyaku Co, Ltd., as well as research grant support from Jansen Pharmaceutical K.K. and Nippon Shinyaku Co, Ltd. NT has received honoraria for lectures from Jansen Pharmaceutical K.K., Nippon Shinyaku Co, Ltd., and Bayer Yakuhin, Ltd., as well as research grant support from Pharmaceutical K.K. and Nippon Shinyaku Co, Ltd. YT has received honoraria for lectures from Jansen Pharmaceutical K.K., Daiichi Sankyo Co, Ltd., and Bayer Yakuhin, Ltd., as well as research grant support from Jansen Pharmaceutical K.K. and Nippon Shinyaku Co, Ltd. SS has received honoraria for lectures from Jansen Pharmaceutical K.K., Nippon Shinyaku Co, Ltd., and Bayer Yakuhin, Ltd. KT has received honoraria for lectures from Jansen Pharmaceutical K.K. and Nippon Shinyaku Co, Ltd. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"282"}}